Pfizer on Monday announced the launch of a large trial to test its investigational oral antiviral drug to prevent COVID-19 infection.
The trial will give participants the treatment, PF-07321332, paired with another medication to see if it prevents COVID-19 infection. The mid-to-late-stage study aims to enroll up to 2,660 healthy ...
from The Washington Times stories: Health https://ift.tt/3CROqhf